TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial by Joshi D, GJ P, Ghosh S, Mohanan A, Joshi S, Mohan V, Chowdhury S, Dutt C, Tandon N

Get full text

Global flood forecasting for averting disasters worldwide by Hirpa, FA, Pappenberger, F, Arnal, L, Baugh, CA, Cloke, HL, Dutra, E, Emerton, RE, Revilla-Romero, B, Salamon, P, Smith, PJ, Stephen, E, Wetterhall, F, Zsoter, E, Theielen-del Pozo, J

Other Authors: “…Schumann, GJ-P…”